Walleye Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$307K Buy
3,300
+1,400
+74% +$124K ﹤0.01% 3050
2025
Q4
$153K Buy
1,900
+1,500
+375% +$126K ﹤0.01% 3670
2025
Q3
$39.1K Sell
400
-9,600
-96% -$773K ﹤0.01% 4085
2025
Q2
$697K Buy
+10,000
New +$571K ﹤0.01% 2350
2025
Q1
Sell
-400
Closed -$27.9K 4162
2024
Q4
$27.9K Sell
400
-2,400
-86% -$199K ﹤0.01% 4457
2024
Q3
$294K Sell
2,800
-5,300
-65% -$620K ﹤0.01% 3736
2024
Q2
$1.15M Buy
8,100
+5,100
+170% +$588K ﹤0.01% 2690
2024
Q1
$335K Sell
3,000
-2,100
-41% -$250K ﹤0.01% 3552
2023
Q4
$661K Buy
5,100
+2,800
+122% +$386K ﹤0.01% 2717
2023
Q3
$375K Sell
2,300
-15,700
-87% -$2.76M ﹤0.01% 3037
2023
Q2
$3.3M Buy
18,000
+5,500
+44% +$792K 0.01% 988
2023
Q1
$1.67M Buy
+12,500
New +$1.47M 0.03% 834

Other funds holding ACLS

Walleye Capital's ACLS Position: Q1 2026 in Review

Walleye Capital sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 108 shares — an estimated $9.56K sold.

Walleye Capital first reported a position in ACLS in Q2 2022 and held it in 9 quarters. The position peaked at $4.68M in Q1 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Walleye Capital reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 108 Axcelis shares in Q1 2026, an estimated $9.56K.
  • Walleye Capital first reported a position in Axcelis in Q2 2022 and held it in 9 quarters.
  • Walleye Capital's Axcelis position peaked at $4.68M in Q1 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.